A phase I/II study of 4?-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patients
1994 ◽
Vol 35
(2)
◽
pp. 174-178
◽
Keyword(s):
Phase I
◽